GoofGoof
Premium Member
The Moderna, Novavax and AstraZeneca vaccines are all also 2 doses. The only one in late stage trials that is potentially one dose is JnJ but they are also testing a 2 dose regiment in their trial so it’s still possible 2 doses may be better. Moderna is still frozen but not as low a temp as Pfizer so can be handled by more traditional vaccine sites like a CVS. JnJ‘s vaccine can be kept in a normal refrigerator.NY Times so take it with a grain of salt. Pfizer’s is also the one that has to be refrigerated and I think 2 dozes is required. There may be other better ones on the way many are in testing and you know these big pharma companies saw big $’s moreso than saving the world
I’m not sure how much money there is to be made from this vaccine. It all depends on how frequently the vaccine is needed in the future. The leading companies are all selling their initial doses of vaccine at not much above break even while there is still a pandemic. The moratorium on profits will roll off in the second half of 2021 so they could in theory raise the prices and make large profits if it’s decided the world needs annual vaccinations. I think the bigger benefit for the pharma companies is to showcase their technology and potentially to use it for other applications. Pfizer and Moderna are both using mRNa vaccines which will be the first time any were successful. The JnJ vaccine showcases a vaccine developed for Ebola that doesn‘t get a lot of headlines since it’s largely a problem in Africa and not in the developed world.